M-PREDROL Drug Patent Profile
✉ Email this page to a colleague
When do M-predrol patents expire, and when can generic versions of M-predrol launch?
M-predrol is a drug marketed by Bel Mar and is included in two NDAs.
The generic ingredient in M-PREDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for M-predrol
A generic version of M-PREDROL was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
Summary for M-PREDROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Patent Applications: | 4,139 |
Formulation / Manufacturing: | see details |
DailyMed Link: | M-PREDROL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for M-PREDROL
US Patents and Regulatory Information for M-PREDROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bel Mar | M-PREDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 086666-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bel Mar | M-PREDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 087135-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |